6th Annual MSK Symposium on Lymphoma


6th Annual MSK Symposium on Lymphoma Banner

Add to Calendar 6th Annual MSK Symposium on Lymphoma 5/13/2022 7:45:00 AM 5/14/2022 1:20:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?P=0&EID=35525 Description: In a rapidly moving landscape, this symposium will offer to discuss with experts how to optimize the use of new therapies in patients with lymphoma. Online false MM/DD/YYYY


Date & Location
Friday, May 13, 2022, 7:45 AM - Saturday, May 14, 2022, 1:20 PM EST

Specialties
Specialties - Anatomic Pathology, Bone Marrow Transplant, Cellular Therapeutics, Hematology, Immunotherapy, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Molecular Pathology, Nuclear Medicine, Oncology and Hematology

Overview

Dr. Gilles Salles welcomes you to the 6th Annual MSK Symposium on Lymphoma.

This symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes. This year, we will address the clinical management of the most frequent lymphoma entities, we will feature focused sessions related to new families of drugs being developed in these areas as well as in less common presentations. Faculty will present those and then discuss during a panel how to best approach patients’ situations. We will also cover in a special session recent advances in the biology of lymphoma and how this will translate to innovative therapeutic interventions. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biomarkers and imaging into clinical practice and clinical trials.

Who Should Attend

The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

Live Virtual Format

This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit and ABIM MOC points will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.


Objectives
  1. Describe recent refinements in lymphoma classification
  2. Discuss first line treatment options in most frequent lymphoma entities
  3. Identify risks/benefits of new approved agents
  4. Implement standard of care changes for patients with lymphoma
  5. Educate patients on the disease and treatment options

Registration

Live Virtual Registration Fees

  • Physicians (MDs, PhDs and DOs): $200
  • Nurses, PAs and Other Healthcare Professionals: $50
  • Residents and Fellows: $50
  • Industry Professionals*: $350

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions

  • A registration discount is available for MSK Alumni, and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Online Registration Deadline 

Online registration is available on the MSK CME Portal until 7:00 AM on May 13, 2022. If you wish to register after this date, please email [email protected] and we will ensure your registration is processed as well as access instructions are emailed to you prior to the start of the course. 

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.